Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin Therapy for Postoperative Hyperglycemia
NCT04554615Completed
- Sponsor
- Tanta University
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of regular human insulin in hyperglycemia (2 arms), sponsored by Tanta University. Primary endpoint: The number of IV-Insulin Therapy sessions required till stabilization of the targeted Blood Glucose level at 180 days. Started Sep 2017; status: completed.
02
Drugs
regular human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT04554615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04554615.